Sotera Health (NASDAQ:SHC) Position Raised by Retirement Systems of Alabama

Retirement Systems of Alabama boosted its position in Sotera Health (NASDAQ:SHC) by 20.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 185,779 shares of the company’s stock after purchasing an additional 32,051 shares during the period. Retirement Systems of Alabama owned approximately 0.07% of Sotera Health worth $3,103,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SHC. CWM LLC grew its stake in shares of Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after purchasing an additional 993 shares during the last quarter. True Wealth Design LLC bought a new stake in Sotera Health during the third quarter worth approximately $32,000. GAMMA Investing LLC boosted its holdings in Sotera Health by 125.0% during the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock worth $50,000 after buying an additional 1,660 shares in the last quarter. Point72 DIFC Ltd grew its position in Sotera Health by 556.6% in the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock worth $78,000 after buying an additional 5,544 shares during the last quarter. Finally, Capital Performance Advisors LLP bought a new position in shares of Sotera Health in the third quarter valued at $91,000. 91.03% of the stock is owned by institutional investors.

Sotera Health Trading Down 0.2 %

Shares of NASDAQ SHC opened at $13.24 on Friday. The business has a 50 day simple moving average of $14.39 and a 200 day simple moving average of $14.21. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.44. The stock has a market cap of $3.75 billion, a price-to-earnings ratio of 52.96 and a beta of 1.96. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The business had revenue of $285.47 million during the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business’s revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.18 earnings per share. On average, research analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SHC has been the topic of a number of recent research reports. Citigroup lifted their target price on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, November 6th. The Goldman Sachs Group started coverage on Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target on the stock. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, Sotera Health presently has a consensus rating of “Moderate Buy” and an average target price of $16.08.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.